We have adapted an assay for the direct detection of Mycobacterium tuberculosis using a prototype automated instrument platform in which probes are amplified with Q-beta replicase. The assay was based on amplification of specific detector probe following four cycles of background reduction (reversible target capture) in a closed disposable pack. The assay signal was the time required for fluorescence to exceed background levels (response time 
Tuberculosis has reemerged in many industrialized nations in recent years as a result of AIDS (9) and changing population dynamics characterized by increased numbers of migrant workers, immigrants, and homeless people (3) . The ability to detect this disease early would potentially decrease morbidity and mortality and lessen its socioeconomic impact. The "gold standard" for definitive diagnosis has remained culture. Traditional culture methods for human specimens can require up to 8 weeks; however, there are shorter culture methods such as those performed with the BACTEC system (Johnson Laboratories, Towson, Md.) and the Septi-Chek AFB system (Becton Dickinson Microbiology Systems, Cockeysville, Md.), allowing presumptive identification in less than 2 weeks. Culture confirmation following these procedures can be completed in hours to several days, depending on the method used.
In the last decade interest has grown in the use of nucleic acid probes as a means for detecting and definitively identifying infectious agents. These tests are highly specific and rapid when compared to conventional culture and have been applied to a wide variety of pathogens. Currently, many of these procedures remain complex and require special facilities, reagents, and training. Other considerations such as ease of use, reproducibility, and amenability to automation remain barriers for wider adoption.
Improved sensitivity of probe tests for mycobacteria has been addressed by target amplification schemes, including PCR (7, 8, 16) , transcription-mediated amplification (10, 17) , ligase chain reaction (LCR) (26) , strand displacement amplification (SDA) (25) , and nucleic acid sequence-based amplification (23) ; by signal or probe amplification approaches, such as approaches that use branched DNA (11) ; and Q-Beta replicase amplification (18, 19) . In manual formats most of these exquisitely sensitive technologies require segregation of laboratory areas, meticulous handling of samples, and special training of diagnostic laboratory personnel.
Q-Beta replicase amplification is based on the use of "detector" probes which are geometrically amplified by Q-Beta replicase following hybridization to specific RNA or DNA targets (13) . In our system, amplification occurs after sample matrix and excess unhybridized detector probe molecules are eliminated from the reaction mixture by using multiple rounds of reversible target capture (RTC) (15, 18) . During RTC, detector probe-target hybrids are "cycled," i.e., sequentially captured, washed, released, and recaptured, on paramagnetic particles. During the first two of four rounds of cycling, two different capture probes, one tailed with 7-deazaguanosine (7-deazaG) and the other tailed with dA, are used to improve specificity and reduce background from signal unhybridized detector probes. Assay conditions and the probe sequence can be adjusted to provide more or less specificity in the detector and capture probes, depending on the sequence heterogeneity in the target molecule population (12) . Capture is achieved by using paramagnetic particles derivatized with an antiligand appropriate for individual capture probe ligand, i.e., oligo (dC) or oligo(dT) for 7-deazaG and dA tailed capture probes, respectively. Previously, we developed a manual assay for Mycobacterium tuberculosis in which probes are amplified with Qbeta replicase (19) . We have since developed a prototype instrument platform, the Galileo instrument, to demonstrate the feasibility of automating assays in a closed disposable cartridge designed to maximize ease of use and to prevent contamination from external sources.
In this report, we describe the detection of M. tuberculosis 23S rRNA targets directly from sputum using Q-Beta replicase amplification and RTC background reduction technology on the Galileo analyzer. We have used this information to determine an assay cutoff for sensitivity and specificity to confer acceptable assay performance for subsequent testing in a clinical trial (20) .
MATERIALS AND METHODS
Oligo(dT) 14 or oligo(dC) 25 magnetic particles. Carboxyl-terminated paramagnetic particles (Advanced Magnetics, Inc., Cambridge, Mass.) were derivatized with either oligo(dT) or oligo(dC). 5Ј-Amino-terminated oligo(dT) 14 or oligo (dC) 25 was synthesized by standard phosphoramidite chemistry. Oligo(dT) 14 or oligo(dC) 25 was linked to carboxyl-terminated paramagnetic particles by methods described previously (15, 19) .
Capture probes. Two single-stranded capture probes (26 and 28 bases in length, respectively), complementary to the same target sequence in the 5Ј region of the M. tuberculosis 23S rRNA, were prepared by ␤-cyanoethyl phosphoramidite chemistry on a 380-B synthesizer (Applied Biosystems, Foster City, Calif.) as described previously (19) . A tail averaging 150 7deazaG residues was added to the 3Ј end of the first capture probe, and a tail of approximately 150 dA residues in length was added to the 3Ј end of the second capture probe by methods described previously (15, 19) .
Preparation of RNA detector probe. The detector probe sequence was complementary to a region of the M. tuberculosis 23S rRNA target a few bases upstream of the annealing site of the capture probes and was inserted into a recombinant plasmid containing the midivariant (MDV) RNA replicator sequence as described previously (19) . This recombinant plasmid was linearized and the RNA detector probe was transcribed with T7 RNA polymerase (Megascript kit; Ambion Inc., Austin, Tex.). After quantitation the RNA was diluted to 10 ng/l and was stored at Ϫ70°C. Approximately 10 11 molecules of MDV detector probe were added to each individual assay mixture (18, 19) .
Bacterial strains. The mycobacterial strains used in this study were obtained from the American Type Culture Collection (Rockville, Md.), were grown by standard procedures (21) , and were homogenized and quantitated as described previously (19) .
Sample processing for M. tuberculosis-inoculated sputum. Mycobacterium culture-negative sputum aliquots of 5 to 10 ml were digested and decontaminated for 15 min with an equal volume of N-acetyl L-cysteine-NaOH. The sediment was resuspended in 45 ml of 0.067 M phosphate buffer (pH 6.8) and was centrifuged at 3,000 ϫ g for 15 min. The wash supernatant was decanted and the pellet was suspended in 2 ml of 0.067 M phosphate buffer (pH 5.3). An appropriate dilution of the mycobacterial culture was added to the resuspended pellet or to 2 ml of 0.067 M phosphate buffer (pH 5.3) to be used as no-matrix controls (i.e., no sputum). Four-hundred-microliter aliquots were heated at 100°C for 15 min. A 350-l portion of this heat-inactivated material was added to a processing tube containing 0.5 g of zirconium oxide beads and 550 l of 5 M guanidinium isothiocyanate (GuSCN) sample processing buffer and was mechanically lysed by shaking at 5,000 rpm for 6 min in the GENE-TRAK Sample Processor as described previously (19, 24) . One-half-milliliter aliquots of processed sample were added to disposable packs for testing on the Galileo analyzer.
Human sputum samples. Previously digested and decontaminated frozen sputum pellets were kindly provided by five geographically distinct teaching hospitals or public health laboratories in the United States. Samples had been stored at Ϫ20 to Ϫ70°C for periods of 2 months to 2 years at those locations. Prior to use in our laboratory, samples were thawed at room temperature and then washed with 0.067 M phosphate buffer (pH 6.8), resuspended in 400 l of the same buffer, and transferred into cryovials for heat inactivation at 100°C for 15 min. The samples then were processed as described above.
Nucleic acid target controls. (i) Purified RNA. rRNA from M. tuberculosis ATCC 25177 was purified and quantitated as described by Barns et al. (2) . A 350-l aliquot of purified RNA at known concentrations in probe dilution buffer was combined with 550 l of 5 M GuSCN sample processing buffer. One-halfmilliliter aliquots of these mixtures (containing either 10 4 or 10 6 molecules per assay) were used to characterize the relationship between input levels of target RNA and assay signal (response time [RT] ) (4, 18) and also to compare the signals produced by various levels of M. tuberculosis cells. These were also used at 10 4 to 10 6 molecules per assay to examine the limit of detection of the assay.
(ii) DNA oligonucleotide controls. A synthetic DNA oligonucleotide target was made by ␤-cyanoethyl phosphoramidite chemistry on a 380-B synthesizer (Applied Biosystems) as described above. This oligonucleotide sequence contained both capture probe and detector probe hybridization sites. These targets were diluted in probe dilution buffer to appropriate concentrations. A 350-l volume of quantitated target preparation was combined with 550 l of 5 M GuSCN sample processing buffer. Five-hundred-microliter aliquots of these preparations, containing either 10 5 or 10 6 molecules, were injected into disposable packs for testing on the Galileo analyzer.
(iii) RNA transcripts. Target transcripts of M. tuberculosis 23S rRNA were used as low-positive controls (10 6 molecules per assay point) and high-positive controls (10 8 molecules per assay point). These were transcribed from a 1,500-nucleotide-long partial cDNA representing the 5Ј end of M. tuberculosis 23S rRNA cloned in the plasmid vector pGEM-3 downstream of a T7 RNA polymerase promoter. The negative control was a Chlamydia trachomatis transcript at a concentration of 10 8 transcripts per assay point, as described previously (18) . All transcripts were synthesized with an Ambion Megascript kit and were diluted and combined with sample processing buffer as described above for use as positive and negative controls. Negative buffer controls containing no targets were prepared by combining 350 l of probe dilution buffer with 550 l of 5 M GuSCN sample processing buffer; 0.5-ml volumes of this mixture were used for testing in the Galileo analyzer.
Instrument processes. (i) Disposable test pack. The disposable test pack ( Fig.  1 ) described below was manufactured of medical-grade Surlyn plastic at GENE-TRAK (Framingham, Mass.) under clean room conditions. The test packs were filled with reagents required for both hybridization chemistry and Q-Beta replicase amplification. The closed disposable test packs consisted of a multicompartment, thermal-formed Surlyn pouch mounted on a rigid polystyrene back plate (7.5 by 36 cm). Reagents were contained in 100-and 200-l blisters (i.e., eight blisters for each of the first two RTC cycles and seven blisters for each of the last two RTC cycles) and two 100-l blisters for amplification reagents. All reagent blisters had pressure-burstable seals and were located on the left side of the pack. The composition of the reagents for the automated assay format was essentially as described previously for the manual version (19) ; however, individual reagent volumes were increased approximately twofold. Individually manufactured lots of test packs were quality control tested for both signal and noise by using positive and negative controls. These data were compared to previously determined empirical specifications prior to acceptance and release of each reagent lot. Two prototype reagent-pack lots were used in the studies described here, i.e., one lot for experiments to investigate matrix effects (data in Table 2 ) and a second lot for all other experiments.
(ii) Galileo analyzer. The Galileo analyzer consisted of two main functional areas, i.e., the carousel and the processing station, which were both maintained at 38°C (14) . All manipulations including sealing, reagent additions, washes, elutions, and magnetic separations were performed in the processing station ( and between the carousel and the processing station. Incubations for hybridization, elutions, and amplification were carried out in the carousel. Prior to processing, packs could also be stored and prewarmed in the carousel. During amplification, an opposable fiber-optic read head was positioned near the read cell of each sample pack. A stationary tungsten lamp and appropriate band-pass filter were used to provide excitation at 535 nm, and fluorescence was read at 615 nm. Fluorescent readings for each pack were taken every 30 s during the 25-min amplification read window (producing 50 datum points per sample). All instrument mechanical functions, data analysis, and user interface functions were controlled by an onboard 386 computer. Once the packs were loaded into the Galileo analyzer, no additional operator steps were required before pack unloading.
(iii) RTC. All steps of RTC described for the manual assay format (19) were performed by the Galileo analyzer at 38°C in the disposable test pack ( Fig. 1) , without operator intervention. During processing, reagent blisters were selectively burst in a predetermined sequence, delivering reagents into the adjacent reaction area. Once they had burst and were emptied, the blisters were permanently heat sealed, thereby isolating reaction areas and controlling the movement of liquids. The central portion of the pack contained four reaction areas in which hybridization, capture, wash steps, magnetic separations, and releases were performed. In each reaction area a single round of RTC chemistry was performed. Four waste areas were positioned on the right side of the pack into which supernatants and washes were directed. Waste areas also were permanently sealed as each round of RTC was completed.
The sample was injected from the rear of the disposable test pack directly into the first reaction area through a Luer port equipped with a one-way valve. Liquid movements within the closed pack were controlled by two rollers on a movable "saddle" assembly in the processing station which transferred supernatants to waste areas, washed and resuspended particles during and after magnetic separations, and transferred liquid eluates into the next reaction area. Magnetic separations were achieved by using the rollers to locate the reaction mixture (containing suspended particles) over the center of the reaction area and positioning permanent magnets against the back plate of the pack. The positioning and timing of roller movement, magnetic separation, and heat sealing were controlled by the instrument software protocol, which was optimized and predetermined empirically.
(iv) Amplification with Q-Beta replicase. The amplification reaction also was performed at 38°C in the lower part of the disposable test pack which contained the nucleotide cocktail and the Q-Beta replicase blisters. The final RTC eluate was delivered to this area, mixed with the nucleotide cocktail and enzyme, and then moved down the channel into the read cell. Amplification conditions were essentially as described previously for the manual assay (19) , with the following modifications. A 200-l volume of the released hybrid complex was added to 100 l of Q-Beta replicase reaction buffer (220 mM Tris [pH 7.8], 64 mM MgCl 2 , 2.4 mM nucleoside triphosphates [GTP, ATP, CTP, and UTP], and 4 g of propidium iodide per ml) and 100 l of Q-Beta replicase stock solution (approximately 110 g of Q-Beta replicase per ml in 25% glycerol). RNA replication occurred if one or more molecules of detector probe was delivered to the amplification reaction. Replicating RNA bound free propidium iodide, resulting in an increased fluorescent signal (4) .
Data analysis. Data were collected as amplification time versus relative fluorescence and was analyzed with a curve-fitting algorithm to calculate the slope of the dye-binding curve and the response time (4). Contaminating RNAs, which arose infrequently, produced dye binding curves with slopes which were higher or lower than that produced by the assay signal probe (4) . Therefore, slope values were used to identify these rare events and to distinguish them from the fluorescence which resulted from replication of the genuine assay signal probe.
Potential statistical differences between the average response time results for distinct sample populations were investigated by the Student t test. For comparisons between populations in which less than 100% of the samples produced response times, a chi-square analysis was performed.
RESULTS

Detection of M. tuberculosis target sequences.
In the Q-Beta replicase amplification assays, the point at which detector probe replication is detected above a baseline value of fluorescence from unbound propidium iodide is termed the RT (4, 18) . The RT is inversely proportional to the logarithm of the number of input detector probe molecules in the amplification reaction and, by extension, the number of target molecules (and organisms) in the original sample. Samples with large numbers of targets have shorter response times than samples containing smaller numbers of targets. Table 1 presents the RTs for various target types and levels which were processed on the Galileo analyzer. Targets included a DNA oligonucleotide containing the M. tuberculosis 23S rRNA target sequence, purified M. tuberculosis total RNA (expressed as 23S rRNA molecules), and sample-processed M. tuberculosis or Mycobacterium avium cells. A target dose-response was evident when various input levels of 23S rRNA targets were assayed. As the levels of 23S rRNA were increased from 10 4 to 10 6 molecules, the average RT decreased from 14.34 to 11.94 min. Samples of rRNA targets introduced into the assay at 10 5 or 10 6 molecules gave average RTs which were not statistically different from those of corresponding levels of the DNA oligonucleotide target (by the Student t test at the 95% confidence level). These results indicated that the assay sensitivity in detecting these different nucleic acid species was equivalent. Table 1 On the other hand, consistent discrimination between 10 CFU of M. tuberculosis (or 10 5 RNA or DNA targets) and negative controls was not observed with these prototype reagents and protocols. While the average RTs were lower for samples containing 10 CFU of M. tuberculosis than for the negative controls (13.91 versus 15.53 min, respectively), when the standard deviations of the two populations of response times are taken into account, the overlap was extensive. Similarly, no significant difference was found between percentages of responders for samples containing 1 CFU of M. tuberculosis, samples to which no target had been added, and samples containing 10 7 CFU of M. avium (chi-square value, 1.22). However, when the percentage of responding samples containing 10 4 M. tuberculosis RNA targets was compared to those for these three latter sample populations, a highly significant value was obtained (chi-square value, 63).
Of the 223 samples with no target tested, 168 (75%) produced no response. The average RT for the remaining 55 samples with no target (15.53 min) was later than the average RT produced by the samples containing 10 4 M. tuberculosis rRNA target molecules (14.34 min) but earlier than the average RT for the 31% of responders from among the samples containing 1 CFU (16.51 min). On the basis of the zero term of the Poisson distribution (ln f[0] ϭ ln [168/223]) the assay delivered an average of approximately 0.283 amplifiable detector probes to the amplification reaction in the absence of the target nucleic acid. The occurrence of responses in these samples with no target was equivalent to assay noise at a level of 1 to 10 CFU and indicated the need to implement an assay cutoff criterion.
Effect of matrix. To examine the effect of the sputum matrix on both noise and signal, uninoculated sputum samples or samples inoculated with 10 4 CFU of M. tuberculosis cells were compared to like samples in buffer ( Table 2 ). The inoculated sputum samples produced an average RT of 11.67 Ϯ 0.70 min which was statistically indistinguishable from that for the inoculated buffer samples (average RT, 11.22 Ϯ 0.69 min). Two of 10 uninoculated sputum samples responded (average RT, 19.54 min), and 4 of 10 uninoculated buffer samples responded (average RT, 22.91 min). A chi-square analysis comparing the frequency of responders in the two categories indicated no statistical difference between these samples (chi square value, 0.92). It should be noted that the RTs presented in Table 2 for  10 4 CFU of M. tuberculosis (with or without sputum) were similar to the average RT for 10 2 CFU of M. tuberculosis in buffer reported in Table 1 . This observation was not unexpected since different lots of prototype reagents with quite different amplification characteristics were used in these experiments (see Discussion).
Clinical samples. Eighty-nine frozen sputum samples from five geographic sites in the United States were rapidly thawed, processed, and then tested on the Galileo analyzer. Six samples were eliminated from the subsequent analysis due to incomplete culture, smear, or patient data or due to pack failure and inadequate sample for repeat testing. a Percentage of total samples tested which exhibited amplification (i.e., responded).
b Average RT and standard deviation (SD) for those samples which responded. NA, not applicable.
c Cultured M. tuberculosis cells were spiked into GuSCN sample processing buffer and were quantitated by plate count.
d Cultured M. tuberculosis cells were spiked into culture-negative human sputum and were processed as described in Materials and Methods. 16 .00 min) which were generally later than those produced by the 81% of assay-and culture-positive, smear-negative samples (average RT, 14.41 min) and the 20% of assay-positive, negative-control samples (average RT, 15.34 min). Analysis of these unresolved Galileo performance data (Fig. 3 ) yielded a sensitivity of 91% and a specificity of 69% versus the culture results.
Resolution of discrepant culture results. Three M. tuberculosis culture-negative samples which were positive on the Galileo analyzer came from patients with previous culture-positive samples and clinical histories of tuberculosis. All three were also PCR positive (data not shown), and two were AFB smear positive. For the final analysis these samples were grouped along with the M. tuberculosis culture-positive samples as clinically positive. Figure 4 compares the Galileo analyzer results with clinical status. We were unable to resolve or reclassify the three assay-negative samples previously reported as culture positive. We speculate that variable handling conditions (e.g., incomplete neutralization after digestion and decontamination) and lengthy storage periods (up to 2 years) may have degraded the target originally present in these samples. Alternatively, the samples originally may have contained very low target levels which were below the detection threshold of the assay.
Setting an RT cutoff. After analysis of the discrepant results, 27% of the M. tuberculosis-negative samples gave a response in the assay. Although the majority of RTs for these samples was later than the average RT for M. tuberculosis-positive samples, it was necessary to implement an RT cutoff to optimize assay specificity. Performance resulting from the use of various cutoff values is presented in Table 4 . A 14-min cutoff value was chosen. This resulted in a sensitivity of 79% and a specificity of 98% for the sample population tested. For this lot of RTC and amplification reagents, a 14-min RT corresponded to approximately 11 molecules of detector probe delivered to the Q-Beta replicase amplification reaction. Equivalent cutoff values for other lots of reagents with different kinetic performance characteristics can be assigned simply by determining the RT corresponding to this number of detector probe molecules.
The positive predictive value (PPV) and the negative predictive value (NPV) for this level of sensitivity and specificity and the disease prevalence in the tested population of samples are 97 and 85%, respectively. Assuming a broader sampling of geographic sites and the more widely accepted general prevalence of M. tuberculosis of 6% and a 14-min cutoff value, we would predict the assay to have a sensitivity of 79%, a specificity of 98%, and a PPV and an NPV of 72 and 99%, respectively (Table 4) . following resolution) were smear positive. Figure 6 presents the results of the final analysis of the sputum testing data after analysis of discrepant results and the use of a 14-min cutoff. The final sensitivity was 79%, with a specificity of 98%.
DISCUSSION
Q-Beta replicase amplification with the prototype automated Galileo platform involved very little specialized training of clinical laboratory personnel since their only involvement was with sample preparation and loading and unloading of packs. The two simple additional steps of heating to ensure complete biological inactivation and cell disruption to liberate targets (24) are minor changes to the current clinical laboratory sample digestion and decontamination protocol. Five hundred microliters of the processed sample was loaded into a syringe and simply introduced through the sample Luer port into the disposable pack; no needle or precision pipetting was required. Once the packs were loaded, the instrument operated unattended until the process was complete and the result was reported. The manipulations for hybridization and detection, which can be cumbersome and prone to errors with other technologies, were performed entirely within the instrument. The sealed disposable test pack serves to prevent "cross talk" between samples, which might otherwise be of particular concern when processing samples containing high, low, or no target loads in the same batch. The sealed disposable test pack also reduced the potential for contamination resulting from the introduction of amplification products from previous assays, as has been reported with amplicons generated in PCRbased amplification assays.
The method of detection of M. tuberculosis that we have described here is directed primarily at RNA targets; however, homologous DNA sequences were detected equally well since similar RTs were seen when equivalent numbers of DNA and RNA targets were analyzed (at target levels of both 10 5 and 10 6 molecules). This suggests the utility of the assay for DNA target assays such as the detection of DNA viruses and antibiotic resistance genes (6). More than 95% of the samples containing 10 4 target molecules responded with an average RT of 14.34 min. One hundred percent of processed sputum sediment samples subsequently inoculated with 10 CFU of M. tuberculosis responded in the assay with an average RT of 13.9 min; however, these samples were not always discriminated from controls. The lower limit of detection showing clear discrimination in this study was 10 to 10 2 CFU of M. tuberculosis or 10 5 to 10 6 RNA or DNA targets (i.e., introduced into the pack as processed sample, prior to RTC and amplification). This limit of detection is a function of the pack and the Galileo platform and not Q-Beta replicase amplification per se, since greater sensitivity had previously been demonstrated in a manual version of the assay (19) . Experiments performed with 32 P-labeled targets and signal probes indicate that the most significant loss of signal from the instrument, relative to that from the manual version of the assay, was due to less efficient release and recapture of target complexes during the four rounds of RTC. This results in reduced cycling efficiency and delivery of less signal to the amplification system (data not shown). Sample matrix frequently perturbs the performance of a variety of diagnostic assays by increasing the background or noise or reducing the signal. Catalytic activity can be inhibited in the early steps of assays which require enzyme amplification, producing false-negative results (1, 5) . Inhibition has been reported to occur in PCR assays for M. tuberculosis in as many as 20% of sputum samples (5) . In Q-Beta replicase assays, the targets are separated from the sample matrix by the RTC steps prior to the amplification stage and the resultant level of inhibitory matrix contaminants is insignificant (1, 19 ). In the current study the absence of sample inhibition was indicated by comparing the average RT for 10 4 CFU of M. tuberculosis inoculated in the sputum matrix (11.67 min) to the same number of CFU inoculated in sample processing buffer (11.22 min) . These values were not statistically different when compared by a Student t test (t ϭ 1.96 with 36 degrees of freedom). Furthermore, the uninoculated sputum and sample processing buffer samples had similar frequencies of responders, indicating that the matrix had no detectable effect on noise.
After resolution of discrepant results (but prior to imposing a cutoff value), 27% (12 of 45) of the M. tuberculosis culturenegative sputum samples gave responses in the assay. This was most likely due to low levels of detector probe (on average, less than 1 molecule) reaching the amplification area. One explanation for these responses is that washing efficiency during RTC is the limiting factor for consistent removal of all unhybridized detector probe prior to the amplification step (data not shown). As a result of this limitation it was essential to impose an RT cutoff to achieve acceptable specificity for a clinical diagnostic assay. The cutoff was defined as an RT above which a given result could be reported as negative. RTs below the cutoff could be reported as positive. We examined a range of cutoff values from 13 to 15 min. With no cutoff and assuming a disease prevalence of 6%, the projected PPV of the assay would have been 18%, with an NPV of 99%. By imposing a cutoff of 14 min, the estimated PPV increased to 72%, while the NPV remained unchanged at 99%. Earlier cutoff times (e.g., 13.5 min) further increased the PPV; however, the NPV fell to 98%. When choosing the final cutoff time, we aimed toward maintaining high specificity and a correspondingly high NPV, reflecting the intended broad clinical application of the assay in populations with a low prevalence of disease.
Eighty-three frozen clinical samples were analyzed on the instrument. One hundred percent (21 of mens responded, but with a later average RT (14.41 min). These observations support the semiquantitative nature of QBeta replicase amplification. The smear-positive samples would be expected, on average, to contain more targets than the smearnegative samples. The average RT for the smear-positive, M. tuberculosis culture-positive samples is lower (i.e., faster) than that for the high-positive control (10.33 min), indicating that on average there were greater than 10 8 targets in these samples, corresponding to approximately 10 4 to 10 5 CFU of M. tuberculosis. After resolution of discrepant results and imposition of a 14-min cutoff, the sensitivity and specificity of the automated assay were 79 and 98%, respectively, and assuming a prevalence of 6%, a PPV and an NPV of 72 and 99%, respectively. This overall sensitivity was lower than we anticipated. However, it is noteworthy that these specimens were not fresh but had been frozen for up to 2 years under variable conditions. The use of fresh samples may increase the sensitivity of the assay.
Prior to resolving the discrepant results, there were 19 smear-positive, culture-positive samples; 2 of the resolved culture-negative, Galileo-positive samples with discrepant results also were smear positive. All of the resulting 21 smear-positive samples from patients with a diagnosis of tuberculosis responded on the Galileo analyzer. Although 10 of 18 MOTT samples were smear positive (indicating high concentrations of organisms), only 3 of 18 produced any RTs, and these were all later than the 14-min cutoff and were easily distinguishable from samples with true-positive results. Therefore, we found 100% sensitivity and specificity for samples in the smear-positive category. These data indicate the utility of the automated test for detecting M. tuberculosis in smear-positive samples.
The Galileo analyzer processed 10 packs per run. The result for the first sample was obtained in approximately 3 h, and all 10 samples were processed in 6.5 h. The instrument could be reloaded with 10 packs near the end of a shift so that it could run overnight or could be loaded intermittently as tests for individual packs were completed.
We have used the Galileo prototype instrument platform as a tool to demonstrate that Q-Beta replicase amplification technology can be simplified and automated. Additional details about the instrument can be found elsewhere (14) . In this early study with an automated format, we have characterized reagent and assay performance and established a suitable assay cutoff value. Further testing at clinical trial sites has been undertaken to verify the practical application of the prototype instrument platform and the performance and robustness of the basic Q-Beta replicase amplification technology and is described in an accompanying report (20) . Finally, we have recently described model assays for several other organisms using Q-Beta replicase amplification and the Galileo platform (6, 22) .
